David Budd

David Budd is currently the Vice President of the Osteoporosis Portfolio at Relation, a role they have held since 2025. They previously served as a Senior Director and Early Development Leader at GSK, overseeing early and mid-stage clinical assets for autoimmune conditions from 2018 to 2023. Earlier in their career, David was a Research Leader at Roche Pharmaceuticals and held various research positions, including Research Investigator II at Novartis and a post-doctoral fellow at the University of Leicester. David earned a PhD in Biochemistry from The University of Dundee and has contributed to academic fields as an honorary lecturer at University College London.